402 related articles for article (PubMed ID: 18832444)
21. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma.
Kim EY; Kim WG; Kim WB; Kim TY; Kim JM; Ryu JS; Hong SJ; Gong G; Shong YK
Clin Endocrinol (Oxf); 2009 Oct; 71(4):581-6. PubMed ID: 19222495
[TBL] [Abstract][Full Text] [Related]
22. [Familial papillary thyroid carcinoma].
Ji Q; Wu Y; Zhu Y; Wang Y; Zhang R; Luo Z
Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):564-6. PubMed ID: 12417064
[TBL] [Abstract][Full Text] [Related]
23. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
24. Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?
Kim YS; Seo M; Park SH; Ju SY; Kim ES
World J Surg; 2020 Sep; 44(9):3022-3027. PubMed ID: 32556933
[TBL] [Abstract][Full Text] [Related]
25. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
[TBL] [Abstract][Full Text] [Related]
26. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
27. Allelic loss of susceptibility loci and the occurrence of BRAF and RAS mutations in patients with familial non-medullary thyroid cancer.
Na KY; Kim RM; Song EM; Lee JH; Lee J; Soh EY
J Surg Oncol; 2012 Jan; 105(1):10-4. PubMed ID: 21826673
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma.
Leung AK; Chow SM; Law SC
Laryngoscope; 2008 Jan; 118(1):32-8. PubMed ID: 18025951
[TBL] [Abstract][Full Text] [Related]
29. Familial papillary thyroid microcarcinoma: a new clinical entity.
Lupoli G; Vitale G; Caraglia M; Fittipaldi MR; Abbruzzese A; Tagliaferri P; Bianco AR
Lancet; 1999 Feb; 353(9153):637-9. PubMed ID: 10030330
[TBL] [Abstract][Full Text] [Related]
30. Micromedullary thyroid cancer: how micro is truly micro?
Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
[TBL] [Abstract][Full Text] [Related]
31. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
[TBL] [Abstract][Full Text] [Related]
32. Unilateral lobectomy for Hurthle cell adenoma.
Wasvary H; Czako P; Poulik J; Lucas R
Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
[TBL] [Abstract][Full Text] [Related]
33. FAMILIAL NON-MEDULLARY THYROID CARCINOMA.
Guda BB; Komisarenko II; Ostafiichuk MV; Tronko MD
Exp Oncol; 2023 Jun; 45(1):70-78. PubMed ID: 37417280
[TBL] [Abstract][Full Text] [Related]
34. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D
Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827
[TBL] [Abstract][Full Text] [Related]
35. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm.
Perrino M; Vannucchi G; Vicentini L; Cantoni G; Dazzi D; Colombo C; Rodari M; Chiti A; Beck-Peccoz P; Fugazzola L
Endocr Relat Cancer; 2009 Mar; 16(1):201-10. PubMed ID: 19106146
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.
Hay ID; Hutchinson ME; Gonzalez-Losada T; McIver B; Reinalda ME; Grant CS; Thompson GB; Sebo TJ; Goellner JR
Surgery; 2008 Dec; 144(6):980-7; discussion 987-8. PubMed ID: 19041007
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Lin JD; Chao TC; Hsueh C
Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
Moses W; Weng J; Kebebew E
Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
[TBL] [Abstract][Full Text] [Related]
39. The Delphian lymph node in thyroid cancer.
Isaacs JD; Lundgren CI; Sidhu SB; Sywak MS; Edhouse PJ; Delbridge LW
Ann Surg; 2008 Mar; 247(3):477-82. PubMed ID: 18376193
[TBL] [Abstract][Full Text] [Related]
40. Recommendation for subclass evaluation of TNM stage iva papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Ann Surg Oncol; 2008 May; 15(5):1511-7. PubMed ID: 18299932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
